Cargando…

A precision approach to breast cancer treatment based on cell lineage-specific vulnerabilities

Detalles Bibliográficos
Autor principal:	Desgrosellier, Jay S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Research Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192127/ https://www.ncbi.nlm.nih.gov/pubmed/34124284 http://dx.doi.org/10.18632/oncoscience.538

Ejemplares similares

FLT3 in lineage specification and plasticity
por: Greenblatt, Sarah, et al.
Publicado: (2012)

Evidence-based medicine and precision medicine: Complementary approaches to clinical decision-making
por: Chow, Ngai, et al.
Publicado: (2018)

PPARs as determinants of the estrogen receptor lineage: use of synthetic lethality for the treatment of estrogen receptor-negative breast cancer
por: Glazer, Robert I., et al.
Publicado: (2017)

A dataset of chromosomal instability gene signature scores in normal and cancer cells from the human breast
por: Baba, Shahnawaz A., et al.
Publicado: (2023)

Patient Enrichment for Precision‐Based Cancer Clinical Trials: Using Prospective Cohort Surveillance as an Approach to Improve Clinical Trials
por: Dalton, William S., et al.
Publicado: (2018)

Importance of Shared Decision-Making for Vulnerable Populations: Examples from Postmastectomy Breast Reconstruction
por: Grabinski, Victoria F., et al.
Publicado: (2018)

A precision environmental health approach to prevention of human disease
por: Baccarelli, Andrea, et al.
Publicado: (2023)

Towards a more precise and individualized assessment of breast cancer risk
por: Wood, Marie E., et al.
Publicado: (2019)

Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy
por: Cuyàs, Elisabet, et al.
Publicado: (2020)

Stem cell-derived three-dimensional (organoid) models of Alzheimer’s disease: a precision medicine approach
por: Kim, Sujung Jun, et al.
Publicado: (2021)

Breast cancer stem cells tolerate chromosomal instability during tumor progression via c-Jun/AXL stress signaling
por: Baba, Shahnawaz A., et al.
Publicado: (2023)

Translational approaches to coagulopathy after trauma: Towards targeted treatment
por: Cohen, Mitchell Jay
Publicado: (2017)

Vulnerability genes or plasticity genes?
por: Belsky, J, et al.
Publicado: (2009)

Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approach
por: Lowe, Leroy, et al.
Publicado: (2022)

Systems and precision medicine approaches to diabetes heterogeneity: a Big Data perspective
por: Capobianco, Enrico
Publicado: (2017)

Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?
por: Sant, Grannum R., et al.
Publicado: (2017)

Multiplex bioimaging of single-cell spatial profiles for precision cancer diagnostics and therapeutics
por: Allam, Mayar, et al.
Publicado: (2020)

Mammary molecular portraits reveal lineage-specific features and progenitor cell vulnerabilities
por: Casey, Alison E., et al.
Publicado: (2018)

The Road Map for Megakaryopoietic Lineage from Hematopoietic Stem/Progenitor Cells
por: Nishikii, Hidekazu, et al.
Publicado: (2017)

Targeting the metastatic niche: Single-cell lineage tracing in prime time
por: Sommer, Elijah R., et al.
Publicado: (2023)

The challenges of dynamic vulnerability and how to assess it
por: de Ruiter, Marleen C., et al.
Publicado: (2022)

A Modern Approach to Endometrial Carcinoma: Will Molecular Classification Improve Precision Medicine in the Future?
por: Marnitz, Simone, et al.
Publicado: (2020)

Single-cell multi-omics and lineage tracing to dissect cell fate decision-making
por: Haghverdi, Laleh, et al.
Publicado: (2023)

An early warning precision public health approach for assessing COVID-19 vulnerability in the UK: the Moore-Hill Vulnerability Index (MHVI)
por: Moore, Harriet, et al.
Publicado: (2023)

Stem-like breast cancer cells in the activated state resist genetic stress via TGFBI-ZEB1
por: Sun, Qi, et al.
Publicado: (2022)

Evidence‐Based Development and Clinical Use of Precision Oncology Therapeutics
por: Comment, Leah A., et al.
Publicado: (2020)

Generating oligodendroglia from adult mesenchymal cells for transplantation: cell reprogramming or direct lineage conversion?
por: Pascual-Guerra, Jorge, et al.
Publicado: (2022)

Ten questions for evolutionary studies of disease vulnerability
por: Nesse, Randolph M
Publicado: (2011)

Vulnerability of Canadian aquatic ecosystems to nuclear accidents
por: Brinkmann, Lars, et al.
Publicado: (2017)

Vulnerability and the Ethics of Human Germline Genome Editing
por: Labude, Markus K., et al.
Publicado: (2022)

Pharmacogenomics based precision medicine in gastroesophageal cancers: way to move forward?
por: Shah, Shrunjal, et al.
Publicado: (2020)

Precision oncology for patients with advanced cancer: the challenges of malignant snowflakes
por: Kurzrock, Razelle, et al.
Publicado: (2015)

Precision Cancer Diagnostics: Tracking Genomic Evolution in Clinical Trials
por: Beca, Francisco, et al.
Publicado: (2016)

Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling
por: Liu, Feng, et al.
Publicado: (2017)

Cancer prevention and screening: the next step in the era of precision medicine
por: Loomans-Kropp, Holli A., et al.
Publicado: (2019)

Philadelphia Chromosome-Positive Leukemia in the Lymphoid Lineage—Similarities and Differences with the Myeloid Lineage and Specific Vulnerabilities
por: Komorowski, Lukasz, et al.
Publicado: (2020)

Integrating single-cell RNA-sequencing and functional assays to decipher mammary cell states and lineage hierarchies
por: Regan, Joseph L., et al.
Publicado: (2020)

Role of the Osteoblast Lineage in the Bone Marrow Hematopoietic Niches
por: Wu, Joy Y, et al.
Publicado: (2009)

Implementing Genomic Clinical Decision Support for Drug‐Based Precision Medicine
por: Freimuth, RR, et al.
Publicado: (2017)

Breast cancer in Brazil: epidemiology and treatment challenges
por: Cecilio, Adma Poliana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_srovnf6a7skgcbumocc1cnbhfu